|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,280.00 KRW | +9.70% |
|
-12.06% | -52.33% |
| 14/04 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 03/04 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 27/07/2026 | 28/07/2026 | 29/07/2026 | 30/07/2026 | 31/07/2026 | |
|---|---|---|---|---|---|
| Last | KRW 3,800.00 | KRW 3,565.00 | KRW 3,100.00 | KRW 2,990.00 | KRW 3,280.00 |
| Volume | 148,913 | 220,374 | 995,620 | 399,917 | 619,637 |
| Change | +1.88% | -6.18% | -13.04% | -3.55% | +9.70% |
| Opening | KRW 3,790.00 | KRW 3,795.00 | KRW 3,570.00 | KRW 3,100.00 | KRW 3,120.00 |
| High | KRW 3,990.00 | KRW 3,795.00 | KRW 3,795.00 | KRW 3,175.00 | KRW 3,310.00 |
| Low | KRW 3,735.00 | KRW 3,510.00 | KRW 3,005.00 | KRW 2,975.00 | KRW 3,060.00 |
Performance
| 1 day | +9.70% | ||
| 1 week | -12.06% | ||
| 1 month | -20.19% | ||
| 3 months | -53.54% | ||
| 6 months | -61.90% | ||
| Current year | -52.33% | ||
| 1 year | +25.91% | ||
| 3 years | -53.77% | ||
| 5 years | -81.83% |
Volumes
marketsDaily volume
619,637
Avg. Volume 20 sessions
366,615
Avg. Volume 20 sessions KRW
1,202,497,200
Avg. Volume 20 sessions USD
836,938.05
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
148,907,713,620
Market Cap (USD)
103,598,785
Net sales ()
24,586,847,080
Net sales (USD)
17,105,679
Free-Float
82.97 %
Free-Float capitalization (KRW)
122,941,544,319
Free-Float capitalization (USD)
85,533,478
Average Daily Capital Traded
0.81%
Indicators
Moving average 5 days
3,347
Moving average 20 days
3,656.5
Moving average 50 days
4,539.4
Moving average 100 days
6,001.1
Price spread / (MMA5)
+2.04%
Price spread / (MMA20)
+11.48%
Price spread / (MMA50)
+38.40%
Price spread / (MMA100)
+82.96%
RSI 9 days
41.17
RSI 14 days
40.87
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.70% | -12.06% | +25.91% | -53.77% | 104M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -0.38% | -0.42% | +58.13% | +73.26% | 25.05B | |
| Weighted average by Cap. | -1.59% | +2.03% | +79.76% | +108.54% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 2,975 |  | 3,990 |
| 1 month | 2,975 | | 4,545 |
| Current year | 2,975 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -52.33% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
